← Leaderboards
Meghan Melinda Morrison Joly
Vanderbilt University
$108,057
Attributed
$108,057
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $56.7K · FY2014–18$100K$75K$50K$25K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$108,057 · 2
By mechanism
F32$81,021 · 1
F31$27,036 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Harold L Moses$33,288,478
- Carlos L Arteaga$27,881,034
- Stephen Ray Hann$10,176,982
- Alissa M Weaver$21,443,335
- Robert J Matusik$12,749,356
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorIn VivoMutantTherapy ResistantResistanceNeoplastic CellGrowthMouse ModelOverexpressionResponseTumor ProgressionAffectPathway InteractionsCellsDuctalExhibitsInhibitor/AntagonistCell GrowthCell DeathApoptosisCell Culture TechniquesChemotherapyCancer TypeAndrogens
Grant awards (3)
The role of neuroendocrine transdifferentiation of pancreatic cancer cells on tumor progression and chemoresistance.$24,327
F32 · FY2018 · CA · contact PI
The role of neuroendocrine transdifferentiation of pancreatic cancer cells on tumor progression and chemoresistance.$56,694
F32 · FY2017 · CA · contact PI
The role of mTORC2 in mammary morphogenesis and HER2-mediated tumorigenesis$27,036
F31 · FY2014 · CA · contact PI